NCT06117709NARecruiting

Integrated Smartphone Technology to Alleviate Malignant Pain (I-STAMP) Testing

Dana-Farber Cancer Institute

Start Date

9/18/2026

Completion Date

4/30/2027

Summary

The purpose of the study is to evaluate if the smartphone app, I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), helps participants with cancer pain manage symptoms and keep track of medications.

Detailed Description

The goal of this study is to develop and refine I-STAMP (Integrated Smartphone Technology to Alleviate Malignant Pain), an electronic health record-integrated mobile health (mHealth) application designed to support advanced cancer patients and care teams in pain management. The research study procedures include screening for eligibility, surveys, and interviews. It is expected that up to 73 participants will take part in this research study. Activities 1-3 are non-interventional and will be used to collect data for application development. Activity 4: This activity will be interventional and will be added with a future amendment.

Eligibility Criteria

Age Range: 21 years to No maximum

Inclusion Criteria for Participants (Activities 1a, 2a, 3a): * Age ≥ 21 years * Current or previous diagnosis of advanced cancer * Current or previous experience with cancer pain Exclusion Criteria for Participants (Activities 1a, 2a, 3a): * Inability to understand, speak, or read English * Any condition that would impede the patient's ability to complete study procedures such as visual impairment or significant cognitive impairment as determined by the participant's treating provider.

Interventions

BEHAVIORAL

I-STAMP

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Advanced CancerPain

Locations

Dana Farber Cancer Institute

Boston, Massachusetts 02215

United States